The pimple sign of progressive supranuclear palsy syndrome

Parkinsonism and Related Disorders

Volumn 20, Issue 2, 2014, Pages 180-185

  Botha, Hugo ^a   Whitwell, Jennifer L ^a   Madhaven, Ajay ^a   Senjem, Matthew L ^a   Lowe, Val ^a   Josephs, Keith A ^a  

^a MAYO CLINIC   (United States)

Author keywords

FDG PET; Midbrain atrophy; Parkinsonism; Pimple sign; PSPS

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN DISEASE; BRAIN SIZE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMAGE ANALYSIS; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PIMPLE SIGN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; VOLUMETRY;

FDG-PET; MIDBRAIN ATROPHY; PARKINSONISM; PIMPLE SIGN; PSPS;

AGED; ATROPHY; FEMALE; GLUCOSE-6-PHOSPHATE; HUMANS; MALE; MESENCEPHALON; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84893645472     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.10.023     Document Type: Article

References (34)

1. Hauw J.J., Daniel S.E., Dickson D., Horoupian D.S., Jellinger K., Lantos P.L., et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994 Nov, 44(11):2015-2019.
2. Dickson D.W., Ahmed Z., Algom A.A., Tsuboi Y., Josephs K.A. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 2010, 23(4):394-400.
3. Lopez O.L., Litvan I., Catt K.E., Stowe R., Klunk W., Kaufer D.I., et al. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 1999, 53(6):1292.
4. Whitwell J.L., Jack C.R., Parisi J.E., Gunter J.L., Weigand S.D., Boeve B.F., et al. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol 2013 Oct, 20(10):1417-1422.
5. Massey La, Micallef C., Paviour D.C., O'Sullivan S.S., Ling H., Williams D.R., et al. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 2012, 27(14):1754-1762.
6. Kato N., Arai K., Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. JNeurol Sci 2003, 210(1-2):57-60.
7. Cosottini M., Ceravolo R., Faggioni L., Lazzarotti G., Michelassi M.C., Bonuccelli U., et al. Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 2007, 116(1):37-42.
8. Quattrone A., Nicoletti G., Messina D., Fera F., Condino F., Pugliese P., et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008, 246(1):214-221.
9. Eckert T., Barnes A., Dhawan V., Frucht S., Gordon M.F., Feigin A.S., et al. FDG PET in the differential diagnosis of parkinsonian disorders. NeuroImage 2005, 26(3):912-921.
10. Mishina M., Ishii K., Mitani K., Ohyama M., Yamazaki M., Ishiwata K., et al. Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy. Acta Neurol Scand 2004, 110(2):128-135.
11. Zhao P., Zhang B., Gao S. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes. Parkinsonism Relat Disord 2012 Jan, 18(Suppl.1):S60-S62.
12. Josephs K.A., Xia R., Mandrekar J., Gunter J.L., Senjem M.L., Jack C.R., et al. Modeling trajectories of regional volume loss in progressive supranuclear palsy. Mov Disord 2013, 00(00):1-8.
13. Litvan I., Hauw J.J., Bartko J.J. Validity and reliability of the preliminary NINDS neuropathological criteria for progressive supranuclear palsy and related disorders. JNeuropathol Exp Neurol 1996, 55(1):97-105.
14. Boeve B.F., Lang A.E., Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003, 54(Suppl.5):S15-S19.
15. Gilman S., Wenning G.K., Low Pa, Brooks D.J., Mathias C.J., Trojanowski J.Q., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71(9):670-676.
16. Litvan I., Bhatia K.P., Burn D.J., Goetz C.G., Lang A.E., McKeith I., et al. Movement disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003, 18(5):467-486.
17. Minoshima S., Frey K.A., Koeppe R.A., Foster N.L., Kuhl D.E. Adiagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. JNucl Med 1995 Jul, 36(7):1238-1248.
18. Jack C.R., Lowe V.J., Senjem M.L., Weigand S.D., Kemp B.J., Shiung M.M., et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008 Mar, 131(Pt 3):665-680.
19. Fujiwara A., Yoshida T., Otsuka T., Hayano F., Asami T., Narita H., et al. Midbrain volume increase in patients with panic disorder. Psychiatry Clin Neurosci 2011 Jun, 65(4):365-373.
20. Whitwell J.L., Crum W.R., Watt H.C., Fox N.C. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol 2001 Sep, 22(8):1483-1489.
21. Simel D.L., Samsa G.P., Matchar D.B. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. JClin Epidemiol 1991, 44(8):763-770.
22. Verny M., Jellinger K.A., Hauw J.J., Bancher C., Litvan I., Agid Y. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neurol Scand 1996, 91(4):427-431.
23. Schrag A., Good C.D., Miszkiel K., Morris H.R., Mathias C.J., Lees aJ., et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000, 54(3):697.
24. Josephs K.A., Whitwell J.L., Dickson D.W., Boeve B.F., Knopman D.S., Petersen R.C., et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008, 29(2):280-289.
25. Price S., Paviour D., Scahill R., Stevens J., Rossor M., Lees A., et al. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. NeuroImage 2004, 23(2):663-669.
26. Boxer A.L., Geschwind M.D., Belfor N., Gorno-Tempini M.L., Schauer G.F., Miller B.L., et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006, 63(1):81-86.
27. Cordato N.J., Duggins aJ., Halliday G.M., Morris J.G.L., Pantelis C. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 2005, 128(Pt 6):1259-1266.
28. Gröschel K., Hauser T.-K., Luft A., Patronas N., Dichgans J., Litvan I., et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. NeuroImage 2004, 21(2):714-724.
29. Stamelou M., de Silva R., Arias-Carrion O., Boura E., Hollerhage M., Oertel W.H., et al. Rational therapeutic approaches to progressive supranuclear palsy. Brain 2010 Jun, 133(Pt 6):1578-1590.
30. Teune L.K., Bartels A.L., de Jong B.M., Willemsen A.T.M., Eshuis Sa, de Vries J.J., et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 2010, 25(14):2395-2404.
31. Hosaka K., Ishii K., Sakamoto S., Mori T., Sasaki M., Hirono N., et al. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. JNeurol Sci 2002, 199(1-2):67-71.
32. Srulijes K., Reimold M., Liscic R.M., Bauer S., Dietzel E., Liepelt-Scarfone I., et al. Fluorodeoxyglucose positron emission tomography in Richardson's syndrome and progressive supranuclear palsy-parkinsonism. Mov Disord 2012, 27(1):151-155.
33. Juh R., Kim J., Moon D., Choe B., Suh T. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. Eur J Radiol 2004, 51(3):223-233.
34. Liscic R.M., Srulijes K., Groger A., Maetzler W., Berg D. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools. Acta Neurol Scand 2013 May, 127(5):362-370.